Items 1 to 10 of about 271673
1. Shu X, Ping M, Yin G, Jiang M: Investigation of Helicobacter <i>pylori</i> infection among symptomatic children in Hangzhou from 2007 to 2014: a retrospective study with 12,796 cases. PeerJ; 2017;5:e2937
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Investigation of Helicobacter <i>pylori</i> infection among symptomatic children in Hangzhou from 2007 to 2014: a retrospective study with 12,796 cases.
  • METHODS: A systematic surveillance of H. <i>pylori</i> infection according to the <sup>13</sup>C-urea breath test was conducted from January 2007 to December 2014 in the Children's hospital, Zhejiang University School of Medicine.
  • RESULTS: A total of 12,796 subjects were recruited and 18.6% children evaluated as H. <i>pylori</i> positive.
  • The annual positive rates decreased from 2007 to 2014 (<i>χ</i><sup>2</sup> = 20.461, <i>p</i> < 0.01).
  • The positive rates were 14.8%, 20.2% and 25.8% in 3-6, 7-11 and 12-17 years age group respectively, which increased with age (<i>χ</i><sup>2</sup> = 116.002, <i>p</i> < 0.01).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Helicobacter. 2009 Sep;14 Suppl 1:52-7 [19712169.001]
  • [Cites] Can J Gastroenterol. 2005 Jul;19(7):399-408 [16010300.001]
  • [Cites] Dig Dis Sci. 2008 Oct;53(10):2650-6 [18270835.001]
  • [Cites] Gastroenterol Res Pract. 2011;2011:940650 [21826138.001]
  • [Cites] Eur J Pediatr. 2010 Jan;169(1):15-25 [19618211.001]
  • [Cites] Helicobacter. 2007 Apr;12(2):164-9 [17309754.001]
  • [Cites] Helicobacter. 2009 Apr;14(2):128-33 [19298340.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Feb;30(2):207-13 [10697142.001]
  • [Cites] Eur J Pediatr. 2013 Nov;172(11):1427-34 [23015042.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2009 Oct 20;89(38):2682-5 [20137267.001]
  • [Cites] Helicobacter. 2012 Oct;17(5):369-73 [22967120.001]
  • [Cites] Gut Pathog. 2016 Mar 15;8:8 [26981156.001]
  • [Cites] Zhongguo Dang Dai Er Ke Za Zhi. 2012 Sep;14(9):675-7 [22989437.001]
  • [Cites] Helicobacter. 2008 Jun;13(3):219-24 [18466397.001]
  • [Cites] J Clin Invest. 2009 Sep;119(9):2475-87 [19729845.001]
  • [Cites] Helicobacter. 2008 Apr;13(2):157-65 [18321305.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):230-43 [21558964.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):428-32 [18030208.001]
  • [Cites] Indian J Gastroenterol. 2014 Jul;33(4):375-82 [24777895.001]
  • [Cites] Gastroenterology. 2006 Jan;130(1):65-72; quiz 211 [16401469.001]
  • [Cites] Helicobacter. 2015 Sep;20 Suppl 1:47-53 [26372825.001]
  • [Cites] Helicobacter. 2014 Sep;19 Suppl 1:1-5 [25167938.001]
  • [Cites] Aliment Pharmacol Ther. 2015 Oct;42(8):1019-26 [26271484.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2006 Apr;42(4):398-404 [16641578.001]
  • [Cites] Helicobacter. 2012 Feb;17(1):23-9 [22221612.001]
  • [Cites] World J Gastroenterol. 2010 Nov 7;16(41):5181-94 [21049552.001]
  • [Cites] Dig Dis Sci. 2006 Dec;51(12):2292-301 [17089189.001]
  • [Cites] J Gastroenterol Hepatol. 2010 Mar;25(3):479-86 [20370726.001]
  • [Cites] Pediatrics. 2010 Mar;125(3):e651-69 [20156901.001]
  • [Cites] Chin Med J (Engl). 2009 Aug 5;122(15):1759-63 [19781321.001]
  • [Cites] Helicobacter. 2012 Sep;17 Suppl 1:1-8 [22958148.001]
  • [Cites] Can J Gastroenterol. 2006 Dec;20(12):770-4 [17171195.001]
  • [Cites] Helicobacter. 2015 Sep;20 Suppl 1:1-7 [26372818.001]
  • [Cites] Helicobacter. 2007 Jun;12(3):258-64 [17493007.001]
  • [Cites] Acta Paediatr. 2007 Jul;96(7):1047-9 [17524023.001]
  • (PMID = 28168109.001).
  • [Journal-full-title] PeerJ
  • [ISO-abbreviation] PeerJ
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; 13C-urea breath test (13C-UBT) / Age / Children / Gastrointestinal symptoms / Gender / Helicobacter pylori (H. pylori)
  •  go-up   go-down


2. Hora M, Eret V, Trávníček I, Procházková K, Pitra T, Dolejšová O, Hes O, Petersson F: Surgical treatment of kidney tumors - contemporary trends in clinical practice. Cent European J Urol; 2016;69(4):341-346
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: During the whole period, the proportions of methods were: ONs 24.8%, LNs 29.4%, ORs 30.3%, LRs 15.6%.
  • But during the years 2014 - III/2016, these changed to 12.6%:26.3%:31.6%:29.4% (in cT1a 1.7%:8.3%:37.8%:52.2%).
  • Category cT1a constitutes in the years 2007 - III/2016 41.3%, in 2014 - III/2016 50.9%.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Can Urol Assoc J. 2014 May;8(5-6):183-9 [25024788.001]
  • [Cites] Eur Urol. 2015 May;67(5):913-24 [25616710.001]
  • [Cites] Int J Urol. 2013 Nov;20(11):1064-71 [23418921.001]
  • [Cites] J Urol. 2015 Oct;194(4):929-38 [25858419.001]
  • [Cites] Rozhl Chir. 2005 May;84(5):246-52 [16045121.001]
  • [Cites] J Urol. 2016 Oct;196(4):989-99 [27157369.001]
  • [Cites] J Endourol. 2016 Jun;30(6):714-21 [27025539.001]
  • [Cites] World J Urol. 2016 Aug;34(8):1053-60 [27178711.001]
  • [Cites] J Urol. 2013 Apr;189(4):1229-35 [23085300.001]
  • [Cites] Lancet. 2016 Feb 27;387(10021):894-906 [26318520.001]
  • [Cites] Cent European J Urol. 2015;68(2):132-6 [26251725.001]
  • [Cites] BJU Int. 2016 Jun;117(6):874-82 [26469291.001]
  • [Cites] J Urol. 2011 Aug;186(2):394-9 [21679982.001]
  • [Cites] Urology. 2016 Jul;93:117-23 [27017902.001]
  • [Cites] Eur Urol. 2016 Jul;70(1):93-105 [26935559.001]
  • [Cites] Cent European J Urol. 2015;68(3):311-7 [26568872.001]
  • [Cites] J Urol. 2011 Nov;186(5):1779-85 [21944105.001]
  • [Cites] Urology. 2016 Apr;90:101-4 [26723181.001]
  • [Cites] Eur Urol. 2012 May;61(5):972-93 [22405593.001]
  • [Cites] Eur Urol. 2015 Dec;68(6):980-92 [25911061.001]
  • [Cites] Cent European J Urol. 2015;68(3):322-9 [26568875.001]
  • [Cites] Urology. 2012 Aug;80(2):286-91 [22704174.001]
  • [Cites] Eur Urol. 2011 Oct;60(4):662-72 [21726933.001]
  • [Cites] J Urol. 2011 Feb;185(2):407-13 [21168170.001]
  • [Cites] Eur Urol. 2011 Sep;60(3):501-15 [21664040.001]
  • [Cites] Urology. 2011 Sep;78(3):555-9 [21777962.001]
  • [Cites] Clin Genitourin Cancer. 2016 Aug;14(4):e335-40 [26880025.001]
  • [Cites] Scand J Urol. 2014 Oct;48(5):445-52 [24666103.001]
  • (PMID = 28127448.001).
  • [ISSN] 2080-4806
  • [Journal-full-title] Central European journal of urology
  • [ISO-abbreviation] Cent European J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  • [Keywords] NOTNLM ; histology / incidence / laparoscopy / nephrectomy / renal tumor
  •  go-up   go-down


3. Cunningham D, Stenning SP, Smyth EC, Okines AF, Allum WH, Rowley S, Stevenson L, Grabsch HI, Alderson D, Crosby T, Griffin SM, Mansoor W, Coxon FY, Falk SJ, Darby S, Sumpter KA, Blazeby JM, Langley RE: Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial. Lancet Oncol; 2017 Mar;18(3):357-370
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients in the investigational group received the same treatment as the control group plus 7·5 mg/kg intravenous bevacizumab on day 1 of every cycle of chemotherapy and for six further doses once every 21 days following chemotherapy, as maintenance treatment.
  • Here, we report the primary analysis results of the trial; all patients have completed treatment and the required number of primary outcome events has been reached.
  • This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN 46020948, and with ClinicalTrials.gov, number NCT00450203.
  • FINDINGS: Between Oct 31, 2007, and March 25, 2014, 1063 patients were enrolled and randomly assigned to receive chemotherapy alone (n=533) or chemotherapy plus bevacizumab (n=530).
  • Wound healing complications were more prevalent in the bevacizumab group, occurring in 53 (12%) patients in this group compared with 33 (7%) patients in the chemotherapy alone group.
  • In patients who underwent oesophagogastrectomy, post-operative anastomotic leak rates were higher in the chemotherapy plus bevacizumab group (23 [10%] of 233 in the chemotherapy alone group vs 52 [24%] of 220 in the chemotherapy plus bevacizumab group); therefore, recruitment of patients with lower oesophageal or junctional tumours planned for an oesophagogastric resection was stopped towards the end of the trial.

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved.
  • [Cites] J Clin Oncol. 2007 Aug 20;25(24):3719-25 [17704421.001]
  • [Cites] Lancet Oncol. 2015 Jun;16(6):656-66 [25975632.001]
  • [Cites] Jpn J Clin Oncol. 2013 Oct;43(10):964-71 [23935207.001]
  • [Cites] N Engl J Med. 2004 Jun 3;350(23 ):2335-42 [15175435.001]
  • [Cites] Br J Cancer. 2011 Jun 7;104(12):1840-7 [21610705.001]
  • [Cites] J Clin Oncol. 2016 Aug 10;34(23):2721-7 [27298411.001]
  • [Cites] Lancet Oncol. 2012 Dec;13(12):1225-33 [23168362.001]
  • [Cites] Medicine (Baltimore). 2015 Oct;94(42):e1489 [26496252.001]
  • [Cites] Lancet Oncol. 2014 Oct;15(11):1224-35 [25240821.001]
  • [Cites] Br J Cancer. 2012 Sep 4;107(6):961-6 [22850548.001]
  • [Cites] Ann Oncol. 2013 Mar;24(3):702-9 [23108952.001]
  • [Cites] Oncology. 2015;88(1):49-56 [25277532.001]
  • [Cites] J Clin Oncol. 2011 Oct 20;29(30):3968-76 [21844504.001]
  • [Cites] Lancet. 2014 Jan 4;383(9911):31-9 [24094768.001]
  • [Cites] J Clin Oncol. 2011 May 1;29(13):1715-21 [21444866.001]
  • [Cites] N Engl J Med. 2012 Jan 26;366(4):310-20 [22276821.001]
  • [Cites] Epidemiology. 1990 Jan;1(1):43-6 [2081237.001]
  • [Cites] Cancer. 2013 Apr 15;119(8):1521-7 [23288663.001]
  • [Cites] Gastric Cancer. 2015 Jan;18(1):168-76 [24557418.001]
  • [Cites] Ann Oncol. 2014 Nov;25(11):2205-10 [25122693.001]
  • [Cites] N Engl J Med. 2006 Jul 6;355(1):11-20 [16822992.001]
  • [Cites] Lancet Oncol. 2013 Sep;14(10):933-42 [23932548.001]
  • [Cites] J Clin Oncol. 2015 Jan 1;33(1):13-21 [25092775.001]
  • [Cites] J Clin Oncol. 2011 Jan 1;29(1):11-6 [20940184.001]
  • (PMID = 28163000.001).
  • [ISSN] 1474-5488
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


4. Persoskie A, O'Brien EK, Nguyen AB, Tworek C: Measuring youth beliefs about the harms of e-cigarettes and smokeless tobacco compared to cigarettes. Addict Behav; 2017 Jul;70:7-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Data from youth in Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2014) were analyzed (N=13,651 youth aged 12-17years).
  • The same pattern held for ratings of SLT as less harmful than cigarettes (indirect: 29.7%; direct: 11.7%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Ltd.
  • [Cites] MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):361-7 [27077789.001]
  • [Cites] Psychol Bull. 2004 Sep;130(5):813-38 [15367082.001]
  • [Cites] Tob Control. 2016 Mar;25(2):174-80 [25361744.001]
  • [Cites] Drug Alcohol Depend. 2013 Aug 1;131(3):214-21 [23746429.001]
  • [Cites] Tob Control. 2014 Sep;23(5):375-84 [24259045.001]
  • [Cites] Tob Regul Sci. 2016 Jan 1;2(1):38-43 [26855966.001]
  • [Cites] Harm Reduct J. 2015 Jul 02;12:21 [26135116.001]
  • [Cites] Pediatrics. 2015 Aug;136(2):308-17 [26216326.001]
  • [Cites] Am J Health Behav. 2015 Jan;39(1):121-31 [25290604.001]
  • [Cites] Am J Public Health. 2013 Nov;103(11):e21-3 [24028247.001]
  • [Cites] Am J Prev Med. 2014 Aug;47(2 Suppl 1):S53-60 [25044196.001]
  • [Cites] J Pers Soc Psychol. 2003 Mar;84(3):608-18 [12635920.001]
  • [Cites] Am J Prev Med. 2014 Feb;46(2):175-8 [24439352.001]
  • [Cites] Drug Alcohol Depend. 2015 Dec 1;157:106-11 [26507173.001]
  • [Cites] Am J Public Health. 2014 Aug;104(8):1437-44 [24922154.001]
  • [Cites] Addiction. 1999 Feb;94(2):269-81 [10396794.001]
  • [Cites] Nicotine Tob Res. 2007 Nov;9(11):1191-6 [17978994.001]
  • [Cites] Pediatrics. 2012 Oct;130(4):e879-85 [22987874.001]
  • [Cites] Health Psychol. 2007 Mar;26(2):136-45 [17385964.001]
  • [Cites] Health Educ Q. 1984 Spring;11(1):1-47 [6392204.001]
  • [Cites] Am J Public Health. 2013 Mar;103(3):556-61 [23327246.001]
  • [Cites] Nicotine Tob Res. 2011 May;13(5):373-83 [21357730.001]
  • [Cites] Tob Control. 2016 Aug 8;: [27507901.001]
  • [Cites] Am J Health Behav. 2015 May;39(3):421-32 [25741686.001]
  • [Cites] Health Psychol. 1988;7(4):355-86 [3049068.001]
  • [Cites] Psychol Addict Behav. 2014 Jun;28(2):367-75 [23647153.001]
  • [Cites] Am J Public Health. 2009 Mar;99(3):487-92 [19106420.001]
  • [Cites] PLoS One. 2015 Dec 17;10(12):e0144827 [26679504.001]
  • [Cites] Nicotine Tob Res. 2015 Mar;17(3):330-6 [25125321.001]
  • [Cites] Addict Behav. 2017 Apr;67:100-105 [28073035.001]
  • [Cites] Nicotine Tob Res. 2007 Oct;9(10 ):1033-42 [17943619.001]
  • [Cites] Tob Control. 2001;10 Suppl 1:i17-23 [11740040.001]
  • [Cites] Tob Control. 2014 Sep;23(5):385-8 [23481906.001]
  • [Cites] Arch Pediatr Adolesc Med. 1999 Sep;153(9):935-41 [10482208.001]
  • [Cites] Prev Med. 2004 Sep;39(3):559-67 [15313096.001]
  • [Cites] Subst Use Misuse. 2015 Jan;50(1):90-8 [25338288.001]
  • (PMID = 28160661.001).
  • [ISSN] 1873-6327
  • [Journal-full-title] Addictive behaviors
  • [ISO-abbreviation] Addict Behav
  • [Language] eng
  • [Grant] United States / Intramural FDA HHS / / FD999999
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; E-cigarettes / Measurement / Perceived harm / Risk perception / Smokeless / Tobacco / Validity
  •  go-up   go-down


5. Arruti M, Piñeiro LD, Salicio Y, Cilla G, Goenaga MA, López de Munain A: Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014). J Neurovirol; 2017 Feb 21;
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).
  • We retrospectively analysed the results of cerebrospinal fluid (CSF) testing in patients older than 65 years between 2007 and 2014 with clinically suspected VZV infection with CNS involvement.
  • The disease was considered to be caused by a VZV infection in 32 patients (11.4%), of which 23 cases were virologically confirmed (detection of VZV DNA in CSF).
  • At the time of discharge, 12 (40%) patients showed neurological sequelae.
  • In conclusion, VZV was the first cause of encephalitis in our elderly population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28224485.001).
  • [ISSN] 1538-2443
  • [Journal-full-title] Journal of neurovirology
  • [ISO-abbreviation] J. Neurovirol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Central nervous system infection / Encephalitis / Epidemiology / Herpes simplex virus / Varicella zoster virus
  •  go-up   go-down


6. Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP, European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease: Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014. Emerg Infect Dis; 2017 Mar;23(3):396-404
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014.
  • We describe the epidemiology of invasive Haemophilus influenzae disease during 2007-2014 in 12 European countries and assess overall H. influenzae disease trends by serotype and patient age.
  • Mean annual notification rate was 0.6 cases/100,000 population, with an increasing annual trend of 3.3% (95% CI 2.3% to 4.3%).
  • The notification rate was highest for patients <1 month of age (23.4 cases/100,000 population).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vaccine. 2015 Nov 17;33(46):6227-34 [26440924.001]
  • [Cites] Lancet Infect Dis. 2008 May;8(5):275-6 [18471770.001]
  • [Cites] Int J Circumpolar Health. 2016 Jan 12;75:29798 [26765260.001]
  • [Cites] Vaccine. 2011 May 17;29(22):3857-62 [21459175.001]
  • [Cites] Vaccine. 2010 May 28;28(24):4073-8 [20398617.001]
  • [Cites] Emerg Infect Dis. 2010 Mar;16(3):455-63 [20202421.001]
  • [Cites] BMC Infect Dis. 2009 Apr 20;9:45 [19379490.001]
  • [Cites] Clin Infect Dis. 2011 Dec;53(12):1230-6 [22080119.001]
  • [Cites] Lancet Infect Dis. 2014 Dec;14(12):1281-92 [25012226.001]
  • [Cites] Wkly Epidemiol Rec. 2006 Nov 24;81(47):445-52 [17124755.001]
  • [Cites] Euro Surveill. 2005 Jul 28;10(7):E050728.4 [16785672.001]
  • [Cites] Clin Microbiol Infect. 2010 Jul;16(7):948-54 [19889054.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):661-8 [20306323.001]
  • [Cites] JAMA. 2014 Mar 19;311(11):1125-32 [24643602.001]
  • [Cites] Clin Infect Dis. 2013 Dec;57(12):1715-21 [24076970.001]
  • [Cites] Clin Infect Dis. 2011 Jul 1;53(1):e1-7 [21653293.001]
  • [Cites] Pediatr Infect Dis J. 2016 Mar;35(3):e76-84 [26569188.001]
  • [Cites] Emerg Infect Dis. 2012 May;18(5):725-32 [22515912.001]
  • [Cites] Pediatrics. 1990 Apr;85(4 Pt 2):631-5 [2179852.001]
  • [Cites] Clin Infect Dis. 2015 Oct 1;61(7):1203-4 [26123935.001]
  • [Cites] Epidemiol Infect. 2013 Sep;141(9):1787-96 [23425638.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2014 Apr;33(4):603-10 [24154654.001]
  • [Cites] Clin Vaccine Immunol. 2012 May;19(5):766-71 [22398246.001]
  • [Cites] Lancet. 1993 Apr 3;341(8849):851-4 [8096561.001]
  • [Cites] Clin Microbiol Rev. 2000 Apr;13(2):302-17 [10756001.001]
  • [Cites] Eur J Public Health. 2008 Aug;18(4):371-5 [18424469.001]
  • [Cites] Vaccine. 2012 Jan 11;30(3):565-71 [22119925.001]
  • [Cites] Clin Infect Dis. 2015 Jun 15;60(12):1786-92 [25784720.001]
  • [Cites] Eur J Clin Microbiol. 1984 Jun;3(3):180-4 [6332016.001]
  • [Cites] PLoS One. 2015 Nov 16;10(11):e0142179 [26569613.001]
  • [Cites] J Infect Dis. 1995 Jan;171(1):93-8 [7798687.001]
  • [Cites] Clin Vaccine Immunol. 2015 May;22(5):459-66 [25787137.001]
  • [Cites] Clin Microbiol Infect. 2012 Sep;18(9):918-23 [22070637.001]
  • [Cites] J Infect. 2012 Dec;65(6):496-504 [22902945.001]
  • [Cites] PLoS One. 2014 Nov 07;9(11):e112711 [25379704.001]
  • [Cites] Clin Microbiol Infect. 2011 Nov;17(11):1638-45 [21054663.001]
  • (PMID = 28220749.001).
  • [ISSN] 1080-6059
  • [Journal-full-title] Emerging infectious diseases
  • [ISO-abbreviation] Emerging Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Europe / bacteria / coccobacillus / epidemiology / invasive Haemophilus influenzae disease / invasive disease / invasive pathogen / serotype / surveillance / temporal trends / vaccine
  •  go-up   go-down


7. Min CK, Kim HO, Lee D, Jung KU, Lee SR, Kim H, Chun HK: Obstructive Left Colon Cancer Should Be Managed by Using a Subtotal Colectomy Instead of Colonic Stenting. Ann Coloproctol; 2016 Dec;32(6):215-220
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Obstructive Left Colon Cancer Should Be Managed by Using a Subtotal Colectomy Instead of Colonic Stenting.
  • PURPOSE: This study compared a subtotal colectomy to self-expandable metallic stent (SEMS) insertion as a bridge to surgery for patients with left colon-cancer obstruction.
  • METHODS: Ninety-four consecutive patients with left colon-cancer obstruction underwent an emergency subtotal colectomy or elective SEMS insertion between January 2007 and August 2014.
  • RESULTS: A subtotal colectomy and SEMS insertion were attempted in 24 and 70 patients, respectively.
  • Laparoscopic surgery was performed more frequently in patients in the SEMS group (62 of 70, 88.6%) than in patients in the subtotal colectomy group (4 of 24, 16.7%).
  • The median number of bowel movements in the subtotal colectomy group was twice per day at postoperative 3-6 months.
  • CONCLUSION: A subtotal colectomy for patients with obstructive left-colon cancer is a clinically and oncologically safer, 1-stage, surgical strategy compared to SEMS insertion as a bridge to surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 2002 Sep;89(9):1096-102 [12190673.001]
  • [Cites] Dis Colon Rectum. 1996 Mar;39(3):329-34 [8603557.001]
  • [Cites] J Gastrointest Surg. 2009 May;13(5):960-5 [19159986.001]
  • [Cites] Clin Endosc. 2014 Sep;47(5):415-9 [25325000.001]
  • [Cites] World J Surg. 2009 Jun;33(6):1281-6 [19363580.001]
  • [Cites] World J Gastroenterol. 2012 Oct 21;18(39):5608-15 [23112555.001]
  • [Cites] Br J Surg. 1994 Sep;81(9):1270-6 [7953385.001]
  • [Cites] Int J Colorectal Dis. 2006 Sep;21(6):538-41 [16228180.001]
  • [Cites] Anticancer Res. 2012 Aug;32(8):3501-5 [22843937.001]
  • [Cites] Dis Colon Rectum. 2004 Nov;47(11):1889-97 [15622582.001]
  • [Cites] Colorectal Dis. 2013 Sep;15(9):1078-85 [23570604.001]
  • [Cites] Dis Colon Rectum. 1998 Jan;41(1):18-22 [9580083.001]
  • [Cites] Int J Colorectal Dis. 2012 Mar;27(3):355-62 [22033810.001]
  • [Cites] World J Gastroenterol. 2014 Sep 7;20(33):11826-34 [25206288.001]
  • [Cites] Br J Surg. 2007 Sep;94(9):1151-4 [17541987.001]
  • [Cites] Br J Surg. 1990 Oct;77(10):1098-102 [2224455.001]
  • [Cites] Ann Surg. 2013 Jul;258(1):107-15 [23324856.001]
  • [Cites] Surg Endosc. 2011 Jun;25(6):1814-21 [21170659.001]
  • [Cites] Br J Surg. 2007 Dec;94(12):1451-60 [17968980.001]
  • [Cites] Br J Surg. 1992 Aug;79(8):839-41 [1393489.001]
  • [Cites] World J Surg. 2011 Aug;35(8):1904-10 [21559998.001]
  • [Cites] Am J Gastroenterol. 2004 Oct;99(10):2051-7 [15447772.001]
  • [Cites] J Gastrointest Surg. 2013 Jun;17(6):1123-9 [23358847.001]
  • [Cites] World J Gastroenterol. 2014 Aug 14;20(30):10570-6 [25132777.001]
  • [Cites] Cancer Epidemiol. 2011 Oct;35(5):442-7 [21470938.001]
  • [Cites] Lancet Oncol. 2011 Apr;12(4):344-52 [21398178.001]
  • [Cites] Br J Surg. 2012 Apr;99(4):469-76 [22261931.001]
  • [Cites] Ann Surg. 2004 Jul;240(1):76-81 [15213621.001]
  • (PMID = 28119864.001).
  • [ISSN] 2287-9714
  • [Journal-full-title] Annals of coloproctology
  • [ISO-abbreviation] Ann Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Colectomy / Colon neoplasms / Intestinal obstruction / Self-expandable metallic stents
  •  go-up   go-down


8. Xu J, Zeng M, Xie J, Wen T, Hu Y: Cementless total hip arthroplasty in patients with ankylosing spondylitis: A retrospective observational study. Medicine (Baltimore); 2017 Jan;96(4):e5813
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to retrospectively analyze the perioperative managements and their outcomes related to performing THA on patients with AS.Data of 54 AS patients who underwent 81 THAs between 2008 and 2014 were retrospectively analyzed.
  • Inclinations and anteversions of acetabular cups were 36.3°±4.5° (range, 30°-50°) and 12.3°±4.9° (range, 0°-25°) respectively.
  • Mean visual analog scale (VAS) score decreased from 6.7 ± 2.1 (range, 4-10) preoperatively to 1.5 ± 1.0 (range, 0-4) at final follow-up, and mean Harris hip score (HHS) improved from 31.2 ± 11.6 (range, 15-45) to 86.1 ± 4.3 (range, 80-95) (P < 0.05).
  • Heterotopic ossification (HO) was documented in 9 hips (11.1%).
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Follow-Up Studies. Hip / physiopathology. Hip / surgery. Humans. Male. Middle Aged. Ossification, Heterotopic / etiology. Postoperative Complications. Postoperative Period. Prosthesis Failure / etiology. Range of Motion, Articular. Retrospective Studies. Sciatic Nerve / injuries. Treatment Outcome. Young Adult


9. Voskoboinik A, Kalman ES, Savicky Y, Sparks PB, Morton JB, Lee G, Kistler PM, Kalman JM: Reduction in radiation dose for atrial fibrillation ablation over time: A 12-year single-center experience of 2344 patients. Heart Rhythm; 2017 Feb 12;
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduction in radiation dose for atrial fibrillation ablation over time: A 12-year single-center experience of 2344 patients.
  • OBJECTIVE: The purpose of this study was to analyze trends in radiation exposure for AF ablation over the last 12 years at our center.
  • Fluoroscopy time, and absorbed and effective doses significantly and progressively decreased over the 12-year period for initial PVI as follows: 2004-2006: 61 ± 27 minutes; 2007-2009: 46 ± 14 minutes, 1365 ± 1369 mGy, 11.3 ± 12.5 mSv; 2010-2012: 31 ± 11, 464 ± 339 mGy, 9.0 ± 10.4 mSv; and 2013-2015: 17 ± 9 minutes, 304 ± 758 mGy, 5.5 ± 6.7 mSv.
  • CF-sensing catheters were used for 357/508 PVI only cases between 2014 and 2015.
  • Fluoroscopy times (11 ± 5 vs 21 ± 8 minutes; P <.001) and absorbed dose (200 ± 524 vs 470 ± 1326 mGy; P = .004) were significantly shorter with this catheter.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28215568.001).
  • [ISSN] 1556-3871
  • [Journal-full-title] Heart rhythm
  • [ISO-abbreviation] Heart Rhythm
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Ablation / Atrial fibrillation / Contact force / Fluoroscopy / Radiation
  •  go-up   go-down


10. Dutra LM, Glantz SA: E-cigarettes and National Adolescent Cigarette Use: 2004-2014. Pediatrics; 2017 Feb;139(2)
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] E-cigarettes and National Adolescent Cigarette Use: 2004-2014.
  • We hypothesized that the decline in youth smoking changed after e-cigarettes arrived on the US market in 2007.
  • METHODS: Data were collected by using cross-sectional, nationally representative school-based samples of sixth- through 12th-graders from 2004-2014 National Youth Tobacco Surveys (samples ranged from 16 614 in 2013 to 25 324 in 2004).
  • Logistic regression was used to identify psychosocial risk factors associated with cigarette smoking in the 2004-2009 samples; this model was then applied to estimate the probability of cigarette smoking among cigarette smokers and e-cigarette users in the 2011-2014 samples.
  • RESULTS: Youth cigarette smoking decreased linearly between 2004 and 2014 (P = .009 for ever smoking and P = .05 for current smoking), with no significant change in this trend after 2009 (P = .57 and .23).
  • Based on the psychosocial model of smoking, including demographic characteristics, willingness to wear clothing with a tobacco logo, living with a smoker, likelihood of smoking in the next year, likelihood of smoking cigarettes from a friend, and use of tobacco products other than cigarettes or e-cigarettes, the model categorized <25% of current e-cigarette-only users (between 11.0% in 2012 and 23.1% in 2013) as current smokers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 by the American Academy of Pediatrics.
  • [Cites] MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):361-7 [27077789.001]
  • [Cites] Swiss Med Wkly. 2016 Jan 11;146:w14271 [26752454.001]
  • [Cites] Tob Control. 2017 Jan;26(1):34-39 [26811353.001]
  • [Cites] J Pediatr Nurs. 2016 Jul-Aug;31(4):373-9 [27079973.001]
  • [Cites] J Health Econ. 2015 Dec;44:300-8 [26583343.001]
  • [Cites] Nicotine Tob Res. 2016 May;18(5):700-7 [26045251.001]
  • [Cites] JAMA Pediatr. 2014 Jul;168(7):610-7 [24604023.001]
  • [Cites] Pediatrics. 2015 Aug;136(2):308-17 [26216326.001]
  • [Cites] Prev Med. 2016 Jun;87:207-12 [26971853.001]
  • [Cites] Tob Control. 2011 Nov;20(6):425-6 [21659450.001]
  • [Cites] Tob Control. 2016 Sep 5;:null [27601455.001]
  • [Cites] Milbank Q. 2016 Sep;94(3):520-96 [27620685.001]
  • [Cites] Pediatrics. 2016 Jul;138(1):null [27296866.001]
  • [Cites] Nicotine Tob Res. 2017 Feb;19(2):149-159 [27613952.001]
  • [Cites] Am J Prev Med. 2015 Aug;49(2):286-93 [25794473.001]
  • [Cites] Am J Prev Med. 2016 Aug;51(2):179-84 [26821834.001]
  • [Cites] Tob Control. 2016 Aug 19;:null [27543564.001]
  • [Cites] Tob Control. 2014 Jul;23 Suppl 3:iii26-30 [24935894.001]
  • [Cites] Fed Regist. 2016 May 10;81(90):28973-9106 [27192730.001]
  • [Cites] Nicotine Tob Res. 2016 May;18(5):708-14 [26568061.001]
  • [Cites] J Adolesc Health. 2015 Dec;57(6):574-9 [26422289.001]
  • [Cites] JAMA. 2014 Jan 8;311(2):135-6 [24399548.001]
  • [Cites] Lancet Respir Med. 2016 Feb;4(2):116-28 [26776875.001]
  • [Cites] Nicotine Tob Res. 2015 Feb;17(2):228-35 [25143298.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):381-5 [25879896.001]
  • [Cites] J Adolesc Health. 2014 Jun;54(6):684-90 [24274973.001]
  • [Cites] Nicotine Tob Res. 2015 Feb;17(2):212-8 [25378683.001]
  • [Cites] Pediatrics. 2014 Jul;134(1):e29-36 [24918224.001]
  • [Cites] Am J Prev Med. 2014 Apr;46(4):395-403 [24650842.001]
  • [Cites] Tob Control. 2016 Mar;25(2):147-52 [25535293.001]
  • [Cites] JAMA. 2015 Aug 18;314(7):700-7 [26284721.001]
  • [Cites] Nicotine Tob Res. 2013 Jan;15(1):158-66 [22529223.001]
  • [Cites] PLoS One. 2016 Mar 04;11(3):e0151022 [26942764.001]
  • [Cites] Oral Oncol. 2016 Jan;52:58-65 [26547127.001]
  • [Cites] Tob Control. 2016 Apr;25(e1):e44-51 [25512432.001]
  • [Cites] Toxicol Res. 2014 Mar;30(1):13-8 [24795794.001]
  • [Cites] JAMA Pediatr. 2015 Nov;169(11):1018-23 [26348249.001]
  • [Cites] Circulation. 2014 May 13;129(19):1972-86 [24821826.001]
  • [Cites] Pediatrics. 2016 Aug;138(2):null [27401102.001]
  • [Cites] Nicotine Tob Res. 2015 Oct;17(10):1212-8 [25358662.001]
  • [Cites] PLoS One. 2014 Sep 22;9(9):e108342 [25244293.001]
  • [Cites] BMJ. 2013 Dec 21;347:f7473 [24361526.001]
  • [Cites] Nicotine Tob Res. 2015 Jul;17(7):810-8 [25385873.001]
  • [Cites] Pediatrics. 2015 Jan;135(1):e43-51 [25511118.001]
  • (PMID = 28115540.001).
  • [ISSN] 1098-4275
  • [Journal-full-title] Pediatrics
  • [ISO-abbreviation] Pediatrics
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P50 CA180890; United States / NCI NIH HHS / CA / R01 CA061021; United States / NIDA NIH HHS / DA / R01 DA043950; United States / NCI NIH HHS / CA / R25 CA113710
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down